Explainer
Microdosing GLP-1s, in plain English
By the TreatmentMD editorial team
Key takeaways
- Microdosing isn't a medical term with one set meaning. It usually means a smaller dose than the usual steps, or doses spaced further apart.1Cedars-SinaiSourceCedars-Sinai. Microdosing semaglutide: does it work for weight loss? August 5, 2026.Open the source All sources2The American Journal of Clinical NutritionSourceMozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344-367.Open the source All sources
- The labels already include lower long-term doses, like 5 mg of Zepbound® or 1.7 mg of Wegovy®. On average, they still help people lose a good amount of weight.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
- Research on very small doses is just getting going, so the right dose is the one you and your clinician choose together.4American Diabetes AssociationSourceAmerican Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S166-S182.Open the source All sources5U.S. National Library of MedicineSourceClinicalTrials.gov. Registered studies of lower, spaced-out or tapered GLP-1 doses, including NCT07092605, NCT07325500, NCT07294950 and NCT07832084, none with results yet. Checked October 14, 2026.Open the source All sources
By the TreatmentMD editorial team
If microdosing keeps popping up in your feed, you're not imagining it. In one large survey of people using GLP-1 shots, nearly one in seven said they'd tried it.6EvidationSourceEvidation. Real-world GLP-1 dosing behaviors: preliminary findings from a microdosing survey. December 16, 2025.Open the source All sources
The idea is simple: a smaller dose, for fewer side effects, a lower bill or an easier way to keep weight off.
Here's what microdosing really means, what's known so far, and how to make a lower dose work for you.
01The short answer
What is GLP-1 microdosing?
Microdosing means taking a GLP-1 at a lower dose than usual. That might be a smaller amount each week, or the same amount spaced further apart, like every other week.2The American Journal of Clinical NutritionSourceMozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344-367.Open the source All sources
It isn't a medical term with one set meaning, though.1Cedars-SinaiSourceCedars-Sinai. Microdosing semaglutide: does it work for weight loss? August 5, 2026.Open the source All sources Some people mean staying on the lowest dose on the label, some mean going below it, and some mean spacing doses out.
02Why people try it
Why are people microdosing?
In that same survey, people gave three main reasons:6EvidationSourceEvidation. Real-world GLP-1 dosing behaviors: preliminary findings from a microdosing survey. December 16, 2025.Open the source All sources
Fewer side effects
An upset stomach is most common while the dose is stepping up, so some people hope a smaller dose will feel gentler.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
A lower bill
Some brand-name cash prices step up with the dose, so a lower dose can cost less.7Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 14, 2026.Open the source All sources8Eli Lilly and CompanySourceLillyDirect. Zepbound® (tirzepatide): self-pay prices and terms. Checked October 14, 2026.Open the source All sources
Keeping weight off
After reaching a goal, some people want to stay on the smallest dose that keeps their progress.4American Diabetes AssociationSourceAmerican Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S166-S182.Open the source All sources
03What the labels say
Are lower doses part of normal treatment?
Yes, in set steps. Every GLP-1 starts at a low dose and steps up slowly, to give your stomach time to adjust.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
And the labels include lower long-term doses, not just the top one:
| Medicine | Starting dose | Long-term doses |
|---|---|---|
| Wegovy® shot | 0.25 mg a week | 1.7 mg or 2.4 mg a week, or 7.2 mg for some people |
| Wegovy® pill | 1.5 mg a day | 25 mg a day |
| Zepbound® | 2.5 mg a week | 5 mg, 10 mg or 15 mg a week |
| Foundayo™ (orforglipron) | 0.8 mg a day | 5.5 mg, or up to 17.2 mg a day |
If a dose doesn't suit you, the labels let your clinician wait longer before the next step, or choose a lower long-term dose.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
The American Diabetes Association agrees: the best dose isn't always the highest one, and some people do better with smaller steps.4American Diabetes AssociationSourceAmerican Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S166-S182.Open the source All sources
04What's known
Does microdosing work?
Lower doses do work, just a little less on average. In Zepbound®'s main study, people on the lowest long-term dose, 5 mg, lost about 15% of their weight in 72 weeks. Those on 15 mg lost about 21%, and everyone also made healthy lifestyle changes.9The New England Journal of MedicineRandomized trial · 2022SURMOUNT-1Mean body weight fell 20.9 percent at the 15 mg dose against 3.1 percent on placebo over 72 weeks.2,539 people · 72 weeks. Adults with BMI 30 or above, or 27 or above with at least one weight-related complication, without diabetes.Tirzepatide once weekly for the treatment of obesity. Jastreboff AM, et al., 2022.Read the study All sources
Plenty of people do well on lower doses in everyday care, too. One large U.S. study followed people without diabetes taking tirzepatide. About three in four were on less than 10 mg by their sixth fill, and those who kept going lost about 12% of their weight in six months.10Diabetes, Obesity and MetabolismSourceHankosky ER, Chinthammit C, Meeks A, et al. Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: results from the Optum Market Clarity database. Diabetes Obes Metab. 2025;27(5):2810-2821.Open the source All sources
Even the very lowest dose helps a little. In one large records study, people who stayed on their starting dose for six months or more lost about 2% to 6% of their weight in a year. That's less than on the usual long-term doses.11Biology Methods and ProtocolsSourceMurugadoss K, Venkatakrishnan AJ, Soundararajan V. Comparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatide. Biol Methods Protoc. 2026;11(1):bpag048.Open the source All sources
Doses below the usual starting doses are a newer area. Researchers are just getting started, and a few studies are under way.5U.S. National Library of MedicineSourceClinicalTrials.gov. Registered studies of lower, spaced-out or tapered GLP-1 doses, including NCT07092605, NCT07325500, NCT07294950 and NCT07832084, none with results yet. Checked October 14, 2026.Open the source All sources
05Keeping it off
Can a lower dose help you keep the weight off?
It can. In one study, people who stepped down from a higher dose of tirzepatide to 5 mg kept about two-thirds of their weight loss a year later. People switched to a placebo (no medicine) kept about two-fifths.12The LancetRandomized trial · 2026SURMOUNT-MAINTAINA year after stepping down to 5 mg, people had kept about two-thirds of the weight they lost, against about two-fifths of those switched to placebo.378 people · 112 weeks: 60 weeks of weight loss, then 52 of maintenance. Adults with obesity, or overweight and a weight-related condition, who lost at least 5% in the first 60 weeks. Funded by Eli Lilly.Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. Horn DB, et al., 2026.Read the study All sources
Doctors also talk about staying on the lowest dose that keeps your progress going, and studies of stepping down slowly are under way.4American Diabetes AssociationSourceAmerican Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S166-S182.Open the source All sources5U.S. National Library of MedicineSourceClinicalTrials.gov. Registered studies of lower, spaced-out or tapered GLP-1 doses, including NCT07092605, NCT07325500, NCT07294950 and NCT07832084, none with results yet. Checked October 14, 2026.Open the source All sources
For the long view, see our guide to how long to stay on a GLP-1. And what happens when you stop explains why some weight often comes back.
06Side effects
Does a lower dose mean fewer side effects?
Often a little. In Zepbound®'s trials, nausea and vomiting were a bit less common on the lowest long-term dose. And most stomach side effects showed up while the dose was stepping up.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Everyone's different, though. Going slowly helps most of all: your clinician can hold you on a dose for longer, or keep you on a lower one.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Our side effects guide has easy tips for the first few weeks.
07Cost
Is microdosing cheaper?
Sometimes. The makers' cash prices for some brand-name medicines step up with the dose. The Wegovy® pill is $149, $199 or $299 a month by dose.7Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 14, 2026.Open the source All sources Zepbound® runs from $299 to $449 a month when you refill on time.8Eli Lilly and CompanySourceLillyDirect. Zepbound® (tirzepatide): self-pay prices and terms. Checked October 14, 2026.Open the source All sources
Many online programs charge the same price at every dose, so a lower dose may not change what you pay there.
Pens and vials are made for a set number of doses, and their instructions say when to start a new one. If cost is the worry, ask your clinician about a lower prescribed dose.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
08Online programs
What about microdose plans from online programs?
Some online programs offer lower-dose or "microdose" plans, usually with compounded semaglutide or tirzepatide.
Compounded medicines are made by state-licensed pharmacies for your prescription.13U.S. Food and Drug AdministrationSourceFDA. Human Drug Compounding. Content current as of June 15, 2026.Open the source All sources As with any plan, a licensed clinician reviews your health, sets your dose and adjusts it with you.
Doses from a vial are measured with a syringe, and the markings depend on the vial's strength. Your pharmacy or clinician can show you exactly where to draw up to.14U.S. Food and Drug AdministrationSourceFDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.Open the source All sources
Our guide to compounded GLP-1s explains how they work.
09Easy habits
How do you try a lower dose the safe way?
Plenty of people try lower doses on their own, but it's easier, and safer, with your clinician on board.6EvidationSourceEvidation. Real-world GLP-1 dosing behaviors: preliminary findings from a microdosing survey. December 16, 2025.Open the source All sources A few simple habits help:
Start with your clinician
Tell them why you're interested, whether it's side effects, cost or keeping weight off. They can shape your plan around it.4American Diabetes AssociationSourceAmerican Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S166-S182.Open the source All sources
Stick to your prescription
Take the dose on your prescription, and let your clinician handle any changes. That way you're never guessing.
Use pens and pills as directed
Pens hold set doses and pills are swallowed whole, so neither is meant to be split.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Keep simple notes
Jot down your dose, your weight and how you feel. It makes check-ins quicker and easier.
10Getting started
Ready to explore your options?
Our ranking puts the licensed programs we rank highest side by side, with their prices and the medicines each one offers. A clinician there can help you find the dose that suits you.
Frequently asked questions.
How much is a microdose?
There's no standard amount.
Programs and studies use different numbers, so your clinician sets any lower dose for you.1Cedars-SinaiSourceCedars-Sinai. Microdosing semaglutide: does it work for weight loss? August 5, 2026.Open the source All sources
Is microdosing safe?
It's still an active medicine, so it's safest with a licensed clinician.
They'll set your dose and check in with you.
The usual side effects can still happen, though they're often a little milder on lower doses.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Is microdosing the same as the starting dose?
Not quite.
Starting doses are the first step on the way up.
Zepbound®'s 2.5 mg, for example, is for starting, not for the long term.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Microdosing usually means staying at or below that first step.
Can I microdose by counting clicks on my pen?
Good question, but the pens aren't made for that.
Ozempic®'s instructions, for one, say not to set a dose by counting clicks.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
If you'd like a lower dose, your clinician can prescribe one.
Can you microdose the Wegovy® pill?
Not by cutting it: the pills are swallowed whole.
The Wegovy® pill comes in set doses, starting at 1.5 mg, and your clinician picks yours.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Can microdosing help with inflammation or menopause?
People are curious, and researchers are just starting to look.5U.S. National Library of MedicineSourceClinicalTrials.gov. Registered studies of lower, spaced-out or tapered GLP-1 doses, including NCT07092605, NCT07325500, NCT07294950 and NCT07832084, none with results yet. Checked October 14, 2026.Open the source All sources
The wider benefits proven so far, like Wegovy®'s heart benefit, come from full doses.
Your clinician can help you weigh what's known.3U.S. Food and Drug AdministrationSourceFDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.All sources
Is microdosing FDA approved?
The doses on each label are.
A dose outside the label is called off-label, and the FDA lets clinicians prescribe one when they judge it's right for you.15U.S. Food and Drug AdministrationSourceFDA. Understanding Unapproved Use of Approved Drugs "Off Label". Content current as of February 5, 2018.Open the source All sources
The bottom line
Microdosing usually means a lower dose of a GLP-1 than the usual steps.
The labels already include lower long-term doses that work well for many people, and research on even smaller ones is just beginning.
The best dose is the one that suits you, set with your clinician.
When you're ready, compare programs on our ranking.
By the TreatmentMD editorial team
Medical disclaimerThis content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any weight-loss program or medication. Individual results may vary.
Sources
- 1Cedars-Sinai. Microdosing semaglutide: does it work for weight loss? August 5, 2026. cedars-sinai.org
- 2Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344-367. doi.org
- 3FDA prescribing information, Medication Guides and Instructions for Use for Wegovy® (injection and tablets), Zepbound®, Foundayo™ and Ozempic®: Indications and Usage; Dosage and Administration; Adverse Reactions; Clinical Studies; Instructions for Use.
- 4American Diabetes Association Professional Practice Committee for Diabetes. 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1):S166-S182. pmc.ncbi.nlm.nih.gov
- 5ClinicalTrials.gov. Registered studies of lower, spaced-out or tapered GLP-1 doses, including NCT07092605, NCT07325500, NCT07294950 and NCT07832084, none with results yet. Checked October 14, 2026. clinicaltrials.gov
- 6Evidation. Real-world GLP-1 dosing behaviors: preliminary findings from a microdosing survey. December 16, 2025. evidation.com
- 7NovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 14, 2026. novocare.com
- 8LillyDirect. Zepbound® (tirzepatide): self-pay prices and terms. Checked October 14, 2026. lilly.com
- 9Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. doi.org
- 10Hankosky ER, Chinthammit C, Meeks A, et al. Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: results from the Optum Market Clarity database. Diabetes Obes Metab. 2025;27(5):2810-2821. doi.org
- 11Murugadoss K, Venkatakrishnan AJ, Soundararajan V. Comparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatide. Biol Methods Protoc. 2026;11(1):bpag048. doi.org
- 12Horn DB, Aronne LJ, Wharton S, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN). Lancet. 2026;407(10545):2305-2318. doi.org
- 13FDA. Human Drug Compounding. Content current as of June 15, 2026. fda.gov
- 14FDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. fda.gov
- 15FDA. Understanding Unapproved Use of Approved Drugs "Off Label". Content current as of February 5, 2018. fda.gov
Product information
- Zepbound® (tirzepatide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with overweight who have at least one weight-related medical condition. It is also approved for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, and should be used in combination with a reduced-calorie diet and increased physical activity.
- Ozempic® (semaglutide) is a prescription-only injectable medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals with type 2 diabetes using the medication.
- Mounjaro® (tirzepatide) is a prescription-only injectable medication FDA-approved for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals using the medication.
- Wegovy® (semaglutide) is a prescription-only injectable or oral medication FDA-approved for chronic weight management in adults with obesity, or adults with overweight and at least one weight-related medical condition, when used alongside a reduced-calorie diet and increased physical activity.
- All medications require a medical evaluation and prescription from a licensed healthcare provider. Individual results may vary.
Important safety information
- Compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies and are not FDA approved. The FDA does not review their safety, effectiveness or quality, and clinical trial results for brand-name drugs do not carry over to them.
- Semaglutide and tirzepatide carry a boxed warning for a risk of thyroid C-cell tumors, based on animal studies, and are not for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, or who is pregnant. Other warnings include pancreatitis, gallbladder problems, and a higher risk of low blood sugar when combined with insulin or a sulfonylurea. The most common side effects are digestive, such as nausea, vomiting, diarrhea and constipation.
- This is a high-level summary, not a complete list. A licensed clinician will review your health history to decide whether a GLP-1 medication is right for you.
